Digital Therapeutics Market
Digital Therapeutics Market Size, Share and Industry Analysis Report By Application (Prediabetes, Nutrition, Care, Diabetes Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS), Disease Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), Substance Abuse and Rehabilitation); By Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer and Pharma) - Forecast Year 2024 – 2031
Healthcare // Healthcare IT
The global Digital Therapeutics market is
foreseen to grow by 33.5%, from USD 4.19 Billion in 2022 to USD 39.57 Billion
in 2030. Increasing incidence of preventable chronic diseases, rising focus on
preventive healthcare, need to control healthcare costs is to drive the market
for the upcoming forecast period. However, patient data privacy concerns remain
one factor hindering the market growth over the anticipated period.
Market Definition
What Is Digital Therapeutics?
Market Overview
Market Segmentation
For the purpose of this report, the global digital
therapeutics market segmented on the basis of application, sales channel, and region:
Application Outlook:
On the basis of application, the market is segmented into preventive
applications, treatment/care-related applications. Further, preventive
applications are segmented into prediabetes, obesity, nutrition, lifestyle
management, other preventive applications. Further, treatment/care-related
applications are segmented into diabetes, CNS disorders, chronic respiratory
disorders, musculoskeletal disorders, cardiovascular diseases, smoking
cessation, medication adherence, gastrointestinal disorders, substance use
& addiction management, rehabilitation & patient care.
Sales Channel Outlook:
On the basis of sales channel, the market is
segmented into b2c, patients, caregivers, b2b, providers, payers, employers,
pharmaceutical companies other buyers.
Figure 1 Digital Therapeutics Market By Sales Channel (Market Size And
Forecast By Value - USD Million, 2022 & 2030)
Regional Outlook (Revenue, USD Million; 2022 & 2030)
|
Regional Outlook (Revenue, USD Million; 2020-2030) |
|
|
North America |
U.S. |
|
Canada |
|
|
Europe |
Germany |
|
U.K. |
|
|
France |
|
|
Spain |
|
|
Italy |
|
|
Rest of the Europe |
|
|
Asia Pacific |
India |
|
Japan |
|
|
China |
|
|
South Korea |
|
|
Australia |
|
|
Rest of Asia-Pacific |
|
|
Middle East & Africa |
UAE |
|
Saudi Arabia |
|
|
South Africa |
|
|
Rest of Middle East &
Africa |
|
|
Latin America |
Brazil |
|
Mexico |
|
|
Argentina |
|
|
Rest of Latin America |
|
Figure 2 Digital Therapeutics Market: Regional Dynamics
Companies Considered And Profiled In This Market Study
The players operating in the market have
undertaken several strategies related to the market in the period 2020-2022.
some of the prominent players in the digital therapeutics market include
·
2MORROW
·
AKILI
·
AYOGO
·
BEHAVR
·
BETTER THERAPEUTICS
·
CANARY HEALTH
·
CLICK THERAPEUTICS
·
COGNIFIT
·
COGNOA
·
FREESPIRA
·
GINGER
·
HINGE HEALTH
·
KAIA HEALTH
·
MINDABLE HEALTH
·
MINDSTRONG HEALTH
·
NOOM
·
OMADA HEALTH
·
OREXO AB
·
PEAR THERAPEUTICS
·
PROPELLER HEALTH
·
TELADOC HEALTH
·
TWILL
·
VIRTA HEALTH CORP
·
WELLDOC
·
WELLTHY
THERAPEUTICS
Global Digital Therapeutics Market Report Scope
|
Historical data |
2020 - 2022 |
|
Base year for estimation |
2022 |
|
Forecast period |
2023 - 2030 |
|
Market size value in 2022 |
USD 4.19 Billion |
|
Revenue forecast in 2030 |
USD 39.57 Billion |
|
Growth Rate |
CAGR of 32.4% from 2023 to 2030 |
|
Quantitative units |
Revenue in USD Million/Billion & CAGR from 2023 to 2030 |
|
Report coverage |
Revenue forecast, company share,
competitive landscape, growth factors, and trends |
|
Segments covered |
Application, Sales Channel |
|
Key companies profiled |
Noom, Teladoc Health, Omada Health |
|
Regional Scope |
North America, Europe, Asia Pacific, Middle East & Africa, Latin
America |
|
Country Scope |
U.S., Canada, Germany, U.K., France, Italy,
Spain, India, Japan, China, Australia, South Korea, Saudi Arabia, UAE, South
Africa, Brazil, Mexico, Argentina |
|
Customization scope |
Free report customization (equivalent to up to 8 analysts’ working
days) with purchase. Addition or alteration to country, regional &
segment scope. |
Application Outlook
(Revenue, USD Million/Billion; 2020-2030)
·
Preventive
Applications
·
Treatment/Care-related
Applications
Sales Channel
Outlook (Revenue, USD Million/Billion; 2020-2030)
·
B2C
·
Patients
·
Caregivers
·
B2B
·
Providers
·
Payers
·
Employers
·
Pharmaceutical
Companies
·
Other Buyers
Regional Outlook (Revenue,
USD Million/Billion; 2020-2030)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
U.K.
o
France
o
Spain
o
Italy
o
Rest of the Europe
·
Asia Pacific
o
India
o
Japan
o
China
o
South Korea
o
Australia
o
Rest of
Asia-Pacific
·
Middle East &
Africa
o
UAE
o
Saudi Arabia
o
South Africa
o
Rest of Middle East
& Africa
·
Latin America
o
Brazil
o
Mexico
o
Argentina
o
Rest of Latin
America
Recent Developments In Digital Therapeutics Market:
|
Chapter
1. Introduction |
|
|
1.1. Market Definition |
|
|
1.2. Research Scope |
|
|
1.2.1. Markets Covered |
|
|
1.2.2. Years Considered for
Study |
|
|
Chapter
2. Executive Summary |
|
|
2.1. Summary Snapshot Market Size
and Forecast, 2020-2030 |
|
|
2.2. Digital Therapeutics Market Share
by Application, 2022 vs 2030 (USD Million) |
|
|
2.3. Digital Therapeutics Market Share
by Sales Channel, 2022 vs 2030 (USD Million) |
|
|
2.4. Digital Therapeutics Market Share
by Region, 2022 vs 2030 (USD Million) |
|
|
Chapter
3. Key Insights |
|
|
Chapter
4. Digital Therapeutics Market Segmentation & Impact Analysis |
|
|
4.1. Digital Therapeutics Market
Indicators Analysis |
|
|
4.1.1. Market Drivers
Analysis |
|
|
4.1.1.1. Increasing
incidence of preventable chronic diseases |
|
|
4.1.1.2. Rising
focus on preventive healthcare |
|
|
4.1.1.3. Need to
control healthcare costs |
|
|
4.1.2. Market Restraint
Analysis |
|
|
4.1.2.1. Patient
data privacy concerns |
|
|
4.1.3. Market Opportunity
Analysis |
|
|
4.1.3.1. Emerging
markets |
|
|
4.2. Regulatory Analysis |
|
|
4.2.1. North America |
|
|
4.2.1.1. U.S. |
|
|
4.2.1.2. Canada |
|
|
4.2.2. Europe |
|
|
4.2.2. Asia Pacific |
|
|
4.2.2.1. India |
|
|
4.2.2.2. Japan |
|
|
4.2.2.3. China |
|
|
4.3. Technological Insights |
|
|
4.4. COVID-19 Impact analysis on Digital
Therapeutics Market |
|
|
4.5. Porter’s Five Forces Analysis |
|
|
4.5.1. Bargaining Power of
Buyers/Consumers |
|
|
4.5.2. Bargaining Power of
Suppliers |
|
|
4.5.3. Threat of New Entrants |
|
|
4.5.4. Threat of Substitute
Products |
|
|
4.5.4. Intensity of Competitive
Rivalry |
|
|
4.6. Competitive Metric Space Analysis |
|
|
Chapter
5. Digital Therapeutics Market, By Application (Market Size and Forecast
by Value - USD Million, 2020 - 2030) |
|
|
5.1. Digital Therapeutics Market, By
Application (Market Size and Forecast by Value - USD Million, 2022 &
2030) |
|
|
5.1.1. Preventive Applications |
|
|
5.1.1.1. Preventive Applications Market Estimates
and Forecast, 2020-2030 (USD Million) |
|
|
5.1.1.2. Preventive Applications Market Estimates
and Forecast, By Region, 2020-2030 (USD Million) |
|
|
5.1.1.3. Prediabetes |
|
|
5.1.1.3.1. Prediabetes Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
|
5.1.1.3.2. Prediabetes Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
|
5.1.1.4. Obesity |
|
|
5.1.1.4.1. Obesity Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
|
5.1.1.4.2. Obesity Market Estimates and Forecast, By Region, 2020-2030
(USD Million) |
|
|
5.1.1.5. Nutrition |
|
|
5.1.1.5.1. Nutrition Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
|
5.1.1.5.2. Nutrition Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
|
5.1.1.6. Lifestyle Management |
|
|
5.1.1.6.1. Lifestyle Management Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
5.1.1.6.2. Lifestyle Management Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
5.1.1.7. Other Preventive Applications |
|
|
5.1.1.7.1. Other Preventive Applications Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
|
5.1.1.7.2. Other Preventive Applications Market Estimates and
Forecast, By Region, 2020-2030 (USD Million) |
|
|
5.1.2. Treatment/Care-related
Applications |
|
|
5.1.2.1.
Treatment/Care-related Applications Market Estimates and Forecast, 2020-2030
(USD Million) |
|
|
5.1.2.2.
Treatment/Care-related Applications Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
|
5.1.2.3. Diabetes |
|
|
5.1.2.3.1. Diabetes Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
|
5.1.2.3.2. Diabetes Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
|
5.1.2.4. CNS Disorders |
|
|
5.1.2.4.1. CNS Disorders Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
|
5.1.2.4.2. CNS Disorders Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
|
5.1.2.5. Chronic Respiratory Disorders |
|
|
5.1.2.5.1. Chronic Respiratory Disorders Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
|
5.1.2.5.2. Chronic Respiratory Disorders Market Estimates and
Forecast, By Region, 2020-2030 (USD Million) |
|
|
5.1.2.6. Musculoskeletal Disorders |
|
|
5.1.2.6.1. Musculoskeletal Disorders Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
5.1.2.6.2. Musculoskeletal Disorders Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
5.1.2.7. Cardiovascular Diseases |
|
|
5.1.2.7.1. Cardiovascular Diseases Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
5.1.2.7.2. Cardiovascular Diseases Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
5.1.2.8. Smoking Cessation |
|
|
5.1.2.8.1. Smoking Cessation Market Estimates and Forecast, 2020-2030
(USD Million) |
|
|
5.1.2.8.2. Smoking Cessation Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
|
5.1.2.9. Medication Adherence |
|
|
5.1.2.9.1. Medication Adherence Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
5.1.2.9.2. Medication Adherence Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
5.1.2.10. Gastrointestinal Disorders |
|
|
5.1.2.10.1. Gastrointestinal Disorders Market Estimates and Forecast,
2020-2018 (USD Million) |
|
|
5.1.2.10.2. Gastrointestinal Disorders Market Estimates and Forecast,
By Region, 2020-2018 (USD Million) |
|
|
5.1.2.11. Substance Use & Addiction Management |
|
|
5.1.2.11.1. Substance Use & Addiction
Management Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
5.1.2.11.2. Substance Use & Addiction Management Market Estimates
and Forecast, By Region, 2020-2030 (USD Million) |
|
|
5.1.2.12. Rehabilitation & Patient Care |
|
|
5.1.2.12.1. Rehabilitation & Patient Care Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
|
5.1.2.12.2.
Rehabilitation & Patient Care Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
|
5.1.2.13. Other Treatment/Care-related Applications |
|
|
5.1.2.13.1. Other Treatment/Care-related Applications Market Estimates
and Forecast, 2020-2018 (USD Million) |
|
|
5.1.2.13.2. Other Treatment/Care-related Applications Market Estimates
and Forecast, By Region, 2020-2018 (USD Million) |
|
|
Chapter
6. Digital Therapeutics Market, By Sales Channel (Market Size and
Forecast by Value - USD Million, 2020 - 2030) |
|
|
6.1. Digital Therapeutics Market, By
Sales Channel (Market Size and Forecast by Value - USD Million, 2022 &
2030) |
|
|
6.1.1. B2C |
|
|
6.1.1.1. B2C Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
6.1.1.2. B2C Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
6.1.2. Patients |
|
|
6.1.2.1. Patients Market Estimates and Forecast,
2020-2030 (USD Million) |
|
|
6.1.2.2. Patients Market Estimates and Forecast, By
Region, 2020-2030 (USD Million) |
|
|
6.1.3. Caregivers |
|
|
6.1.3.1. Caregivers
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
6.1.3.2. Caregivers
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
6.1.4. B2B |
|
|
6.1.4.1. B2B Market
Estimates and Forecast, 2020-2030 (USD Million) |
|
|
6.1.4.2. B2B Market
Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
6.1.5. Providers |
|
|
6.1.5.1. Providers
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
6.1.5.2. Providers
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
6.1.6. Payers |
|
|
6.1.6.1. Payers Market Estimates and
Forecast, 2020-2030 (USD Million) |
|
|
6.1.6.2. Payers
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
6.1.7. Employers |
|
|
6.1.7.1. Employers
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
6.1.7.2. Employers
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
6.1.8. Pharmaceutical Companies |
|
|
6.1.8.1.
Pharmaceutical Companies Market Estimates and Forecast, 2020-2030 (USD
Million) |
|
|
6.1.8.2.
Pharmaceutical Companies Market Estimates and Forecast, By Region, 2020-2030
(USD Million) |
|
|
6.1.9. Other Buyers |
|
|
6.1.9.1. Other
Buyers Market Estimates and Forecast, 2020-2030 (USD Million) |
|
|
6.1.9.2. Other
Buyers Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
|
Chapter
7. Digital Therapeutics Market, By Region (Market Size and Forecast by Value
- USD Million, 2020 - 2030) |
|
|
7.1. Digital Therapeutics Market, By
Region (Market Size and Forecast by Value - USD Million, 2022 & 2030) |
|
|
7.2. North America |
|
|
7.2.1. North America Digital
Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.2.2. North America Digital Therapeutics
Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.2.3. North America Digital
Therapeutics Market, By Country, 2020-2030 (USD Million) |
|
|
7.2.4. U.S. |
|
|
7.2.4.1. U.S.
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.2.4.2. U.S.
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.2.5. Canada |
|
|
7.2.5.1. Canada
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.2.5.2. Canada
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.3. Europe |
|
|
7.3.1. Europe Digital
Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.3.2. Europe Digital
Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.3.3. Europe Digital Therapeutics
Market, By Country, 2020-2030 (USD Million) |
|
|
7.3.4. Germany |
|
|
7.3.4.1. Germany
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.3.4.2. Germany
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.3.5. U.K. |
|
|
7.3.5.1. U.K.
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.3.5.2. U.K.
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.3.6. France |
|
|
7.3.6.1. France
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.3.6.2. France
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.3.7. Spain |
|
|
7.3.7.1. Spain
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.3.7.2. Spain
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.3.8. Italy |
|
|
7.3.8.1. Italy
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.3.8.2. Italy
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.3.9. Rest of Europe |
|
|
7.3.9.1. Rest of
Europe Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.3.9.2. Rest of
Europe Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.4. Asia Pacific |
|
|
7.4.1. Asia Pacific Digital
Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.4.2. Asia Pacific Digital
Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.4.3. Asia Pacific Digital
Therapeutics Market, By Country, 2020-2030 (USD Million) |
|
|
7.4.4. India |
|
|
7.4.4.1. India
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.4.4.2. India
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.4.4.3. India
Digital Therapeutics Market, By , 2020-2030 (USD Million) |
|
|
7.4.5. Japan |
|
|
7.4.5.1. Japan Digital
Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.4.5.2. Japan
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.4.5.3. Japan
Digital Therapeutics Market, By , 2020-2030 (USD Million) |
|
|
7.4.6. China |
|
|
7.4.6.1. China
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.4.6.2. China
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.4.6.3. China
Digital Therapeutics Market, By , 2020-2030 (USD Million) |
|
|
7.4.7. South Korea |
|
|
7.4.7.1. South
Korea Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.4.7.2. South
Korea Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.4.7.3. South Korea Digital
Therapeutics Market, By , 2020-2030 (USD Million) |
|
|
7.4.8. Australia |
|
|
7.4.8.1.
Australia Digital Therapeutics Market, By Application, 2020-2030 (USD
Million) |
|
|
7.4.8.2.
Australia Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD
Million) |
|
|
7.4.8.3.
Australia Digital Therapeutics Market, By , 2020-2030 (USD Million) |
|
|
7.4.9. Rest of Asia Pacific |
|
|
7.4.9.1. Rest of
Asia Pacific Digital Therapeutics Market, By Application, 2020-2030 (USD
Million) |
|
|
7.4.9.2. Rest of
Asia Pacific Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD
Million) |
|
|
7.4.9.3. Rest of
Asia Pacific Digital Therapeutics Market, By , 2020-2030 (USD Million) |
|
|
7.5. Middle East & Africa |
|
|
7.5.1. Middle East & Africa
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.5.2. Middle East &
AfricaDigital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.5.3. Middle East & Africa
Digital Therapeutics Market, By Country, 2020-2030 (USD Million) |
|
|
7.5.4. UAE |
|
|
7.4.5.1. UAE
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.4.5.2. UAE
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.5.5. Saudi Arabia |
|
|
7.5.5.1. Saudi
Arabia Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.5.5.2. Saudi
Arabia Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.5.6. South Africa |
|
|
7.5.6.1. South
Africa Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.5.6.2. South
Africa Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.5.7. Rest of Middle East
& Africa |
|
|
7.5.7.1. Rest of
Middle East & Africa Digital Therapeutics Market, By Application,
2020-2030 (USD Million) |
|
|
7.5.7.2. Rest of
Middle East & Africa Digital Therapeutics Market, By Sales Channel,
2020-2030 (USD Million) |
|
|
7.6. Latin America |
|
|
7.6.1. Latin America Digital
Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.6.2. Latin America Digital
Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.6.3. Latin America Digital Therapeutics
Market, By Country, 2020-2030 (USD Million) |
|
|
7.6.4. Brazil |
|
|
7.6.4.1. Brazil
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.6.4.2. Brazil
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.6.5. Mexico |
|
|
7.6.5.1. Mexico
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
|
7.6.5.2. Mexico
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
|
7.6.6. Argentina |
|
|
7.6.6.1.
Argentina Digital Therapeutics Market, By Application, 2020-2030 (USD
Million) |
|
|
7.6.6.2.
Argentina Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD
Million) |
|
|
7.6.7. Rest of Latin America |
|
|
7.6.7.1. Rest of
Latin America Digital Therapeutics Market, By Application, 2020-2030 (USD
Million) |
|
|
7.6.7.2. Rest of
Latin America Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD
Million) |
|
|
Chapter
8. Competitive Landscape |
|
|
8.1. Market Revenue Share by
Manufacturers |
|
|
8.2. Competitor’s Positioning |
|
|
8.3. Strategy Benchmarking |
|
|
8.3.1. Partnership &
Agreement |
|
|
8.3.2. New Product Development |
|
|
8.3.3. Mergers &
Acquisitions |
|
|
8.3.4. Investment &
Expansion |
|
|
8.4. Vendor Landscape |
|
|
8.4.1. Distributors |
|
|
8.4.2. North America |
|
|
8.4.3. Europe |
|
|
8.4.4. Asia Pacific |
|
|
8.4.5. Middle East &
Africa |
|
|
8.4.6. Latin America |
|
|
8.5. Zettabyte Analytics Insights for
Competitive Landscape |
|
|
Chapter
9. Company Profiles |
|
|
9.1. 2Morrow |
|
|
9.1.1. Company Overview |
|
|
9.1.2. Products Offered |
|
|
9.1.3. Financials |
|
|
9.1.4. Recent Development |
|
|
9.2. Akili |
|
|
9.2.1. Company Overview |
|
|
9.2.2. Products Offered |
|
|
9.2.3. Financials |
|
|
9.2.4. Recent Development |
|
|
9.3. Ayogo |
|
|
9.3.1. Company Overview |
|
|
9.3.2. Products Offered |
|
|
9.3.3. Financials |
|
|
9.3.4. Recent Development |
|
|
9.4. Behavr |
|
|
9.4.1. Company Overview |
|
|
9.4.2. Products Offered |
|
|
9.4.3. Financials |
|
|
9.4.4. Recent Development |
|
|
9.5. Better Therapeutics |
|
|
9.5.1. Company Overview |
|
|
9.5.2. Products Offered |
|
|
9.5.3. Financials |
|
|
9.5.4. Recent Development |
|
|
9.6. Canary Health |
|
|
9.6.1. Company Overview |
|
|
9.6.2. Products Offered |
|
|
9.6.3. Financials |
|
|
9.6.4. Recent Development |
|
|
9.7. Click Therapeutics |
|
|
9.7.1. Company Overview |
|
|
9.7.2. Products Offered |
|
|
9.7.3. Financials |
|
|
9.7.4. Recent Development |
|
|
9.8. Cognifit |
|
|
9.8.1. Company Overview |
|
|
9.8.2. Products Offered |
|
|
9.8.3. Financials |
|
|
9.8.4. Recent Development |
|
|
9.9. Cognoa |
|
|
9.9.1. Company Overview |
|
|
9.9.2. Products Offered |
|
|
9.9.3. Financials |
|
|
9.9.4. Recent Development |
|
|
9.10. Freespira |
|
|
9.10.1. Company Overview |
|
|
9.10.2. Products Offered |
|
|
9.10.3. Financials |
|
|
9.10.4. Recent
Development |
|
|
9.11. Ginger |
|
|
9.11.1. Company Overview |
|
|
9.11.2. Products Offered |
|
|
9.11.3. Financials |
|
|
9.11.4. Recent
Development |
|
|
9.12. Hinge Health |
|
|
9.12.1. Company Overview |
|
|
9.12.2. Products Offered |
|
|
9.12.3. Financials |
|
|
9.12.4. Recent
Development |
|
|
9.13. Kaia Health |
|
|
9.13.1. Company Overview |
|
|
9.13.2. Products Offered |
|
|
9.13.3. Financials |
|
|
9.13.4. Recent
Development |
|
|
9.14. Mindable Health |
|
|
9.14.1. Company Overview |
|
|
9.14.2. Products Offered |
|
|
9.14.3. Financials |
|
|
9.14.4. Recent
Development |
|
|
9.15. Mindstrong Health |
|
|
9.15.1. Company Overview |
|
|
9.15.2. Products Offered |
|
|
9.15.3. Financials |
|
|
9.15.4. Recent
Development |
|
|
9.16. Noom |
|
|
9.16.1. Company Overview |
|
|
9.16.2. Products Offered |
|
|
9.16.3. Financials |
|
|
9.16.4. Recent
Development |
|
|
9.17. Omada Health |
|
|
9.17.1. Company Overview |
|
|
9.17.2. Products Offered |
|
|
9.17.3. Financials |
|
|
9.17.4. Recent
Development |
|
|
9.18. Orexo Ab |
|
|
9.18.1. Company Overview |
|
|
9.18.2. Products Offered |
|
|
9.18.3. Financials |
|
|
9.18.4. Recent
Development |
|
|
9.19. Pear Therapeutics |
|
|
9.19.1. Company Overview |
|
|
9.19.2. Products Offered |
|
|
9.19.3. Financials |
|
|
9.19.4. Recent
Development |
|
|
9.20. Propeller Health |
|
|
9.20.1. Company Overview |
|
|
9.20.2. Products Offered |
|
|
9.20.3. Financials |
|
|
9.20.4. Recent
Development |
|
|
9.21. Teladoc Health |
|
|
9.21.1. Company Overview |
|
|
9.21.2. Products Offered |
|
|
9.21.3. Financials |
|
|
9.21.4. Recent
Development |
|
|
9.22. Twill |
|
|
9.22.1. Company Overview |
|
|
9.22.2. Products Offered |
|
|
9.22.3. Financials |
|
|
9.22.4. Recent
Development |
|
|
9.23. Virta Health Corp |
|
|
9.23.1. Company Overview |
|
|
9.23.2. Products Offered |
|
|
9.23.3. Financials |
|
|
9.23.4. Recent
Development |
|
|
9.24. Welldoc |
|
|
9.24.1. Company Overview |
|
|
9.24.2. Products Offered |
|
|
9.24.3. Financials |
|
|
9.24.4. Recent
Development |
|
|
9.25. Wellthy Therapeutics |
|
|
9.25.1. Company Overview |
|
|
9.25.2. Products Offered |
|
|
9.25.3. Financials |
|
|
9.25.4. Recent
Development |
|
|
Chapter
10. Research Methodology |
|
|
10.1. Research Sources |
|
|
10.1.1. Primary |
|
|
10.1.2. Secondary |
|
|
10.2. Market Size Estimation |
|
|
Chapter
11. Appendix |
|
|
11.1.
Discussion guide |
|
|
11.2.
Knowledge Store: Zettabyte Analytics Subscription Portal |
|
|
11.3.
Available Customizations |
|
|
11.4.
Associated Zettabyte Analytics Reports |
|
|
List of
Tables |
|
|
Table 1 |
Digital
Therapeutics Market, By Application (Market Size and Forecast by Value - USD
Million, 2022 & 2030) |
|
Table 2 |
Preventive
Applications Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 3 |
Preventive
Applications Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
Table 4 |
Treatment/Care-related
Applications Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 5 |
Treatment/Care-related
Applications Market Estimates and Forecast, By Region, 2020-2030 (USD
Million) |
|
Table 6 |
Digital
Therapeutics Market, By Sales Channel (Market Size and Forecast by Value -
USD Million, 2022 & 2030) |
|
Table 7 |
B2C
Market Estimates and Forecast, 2020-2030 (USD Million) |
|
Table 8 |
B2C
Market Estimates and Forecast, By Region, 2020-2030 (USD Million) |
|
Table 10 |
Market Estimates and Forecast, 2020-2030
(USD Million) |
|
Table 11 |
Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
Table 12 |
Market Estimates and Forecast, 2020-2030
(USD Million) |
|
Table 13 |
Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
Table 14 |
Market Estimates and Forecast, 2020-2030
(USD Million) |
|
Table 15 |
Market Estimates and Forecast, By Region,
2020-2030 (USD Million) |
|
Table 16 |
North
America Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 17 |
North
America Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD
Million) |
|
Table 19 |
North
America Digital Therapeutics Market, By Country, 2020-2030 (USD Million) |
|
Table 20 |
U.S.
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 21 |
U.S.
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 23 |
Canada
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 24 |
Canada
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 26 |
Europe
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 27 |
Europe
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 29 |
Europe
Digital Therapeutics Market, By Country, 2020-2030 (USD Million) |
|
Table 30 |
Germany
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 31 |
Germany
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 33 |
U.K.
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 34 |
U.K.
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 36 |
France
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 37 |
France
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 39 |
Spain
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 40 |
Spain
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 42 |
Italy
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 43 |
Italy
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 45 |
Rest of
Europe Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 46 |
Rest of
Europe Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 48 |
Asia
Pacific Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 49 |
Asia
Pacific Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD
Million) |
|
Table 51 |
Asia
Pacific Digital Therapeutics Market, By Country, 2020-2030 (USD Million) |
|
Table 52 |
India
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 53 |
India
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 55 |
Japan
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 56 |
Japan
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 58 |
China
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 59 |
China
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 61 |
South
Korea Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 62 |
South
Korea Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 64 |
Australia
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 65 |
Australia
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 67 |
Rest of
Asia Pacific Digital Therapeutics Market, By Application, 2020-2030 (USD
Million) |
|
Table 68 |
Rest of
Asia Pacific Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD
Million) |
|
Table 70 |
Middle
East & Africa Digital Therapeutics Market, By Application, 2020-2030 (USD
Million) |
|
Table 71 |
Middle
East & Africa Digital Therapeutics Market, By Sales Channel, 2020-2030
(USD Million) |
|
Table 73 |
Middle
East & Africa Digital Therapeutics Market, By Country, 2020-2030 (USD
Million) |
|
Table 74 |
UAE
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 75 |
UAE
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 77 |
Saudi
Arabia Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 78 |
Saudi
Arabia Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 80 |
South
Africa Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 81 |
South
Africa Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 83 |
Rest of
Middle East & Africa Digital Therapeutics Market, By Application,
2020-2030 (USD Million) |
|
Table 84 |
Rest of
Middle East & Africa Digital Therapeutics Market, By Sales Channel,
2020-2030 (USD Million) |
|
Table 86 |
Latin
America Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 87 |
Latin America
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 89 |
Latin
America Digital Therapeutics Market, By Country, 2020-2030 (USD Million) |
|
Table 90 |
Brazil
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 91 |
Brazil
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 93 |
Mexico
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 94 |
Mexico
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 96 |
Argentina
Digital Therapeutics Market, By Application, 2020-2030 (USD Million) |
|
Table 97 |
Argentina
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million) |
|
Table 99 |
Rest of
Latin America Digital Therapeutics Market, By Application, 2020-2030 (USD
Million) |
|
Table 100 |
Rest of
Latin America Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD
Million) |
|
Table 102 |
Product
Launch & Development in The Digital Therapeutics Market, 2020-2022 |
|
Table 103 |
Investment
and Expansion in The Digital Therapeutics Market, 2020-2022 |
|
Table 104 |
Partnership
& Collaboration in The Digital Therapeutics Market, 2020-2022 |
|
Table 105 |
Merger
& Acquisition in The Digital Therapeutics Market, 2020-2022 |
|
List of Figures |
|
|
Figure 1 |
Research
Methodology |
|
Figure 2 |
Summary
Snapshot Market Size and Forecast, USD Million, 2022 & 2030 |
|
Figure 3 |
Global
Digital Therapeutics Market Segmentation & Impact Analysis |
|
Figure 4 |
Regulatory
Analysis |
|
Figure 5 |
COVID-19
Impact analysis on Digital Therapeutics Market |
|
Figure 6 |
Market
Revenue Share by Manufacturers |
|
Figure 7 |
Digital
Therapeutics Market, By Application (Market Size and Forecast by Value - USD
Million, 2022 & 2030) |
|
Figure 8 |
Digital
Therapeutics Market, By Sales Channel (Market Size and Forecast by Value -
USD Million, 2022 & 2030) |
|
Figure 10 |
Digital
Therapeutics Market, By Region (Market Size and Forecast by Value - USD
Million, 2022 & 2030) |
1.
Research Sources
We at Zettabyte Analytics have a
detailed and related research methodology focussed on estimating the market
size and forecasted value for the given market. Comprehensive research
objectives and scope were obtained through secondary research of the parent and
peer markets. The next step was to validate our research by various market
models and primary research. Both top-down and bottom-up approaches were
employed to estimate the market. In addition to all the research reports, data
triangulation is one of the procedures used to evaluate the market size of
segments and sub-segments.
Research Methodology
1.1. Secondary Research
The secondary research study involves various sources and databases used
to analyze and collect information for the market-oriented survey of a specific
market. We use multiple databases for our exhaustive secondary research, such
as Factiva, Dun & Bradstreet, Bloomberg, Research article, Annual reports,
Press Release, and SEC filings of significant companies. Apart from this, a
dedicated set of teams continuously extracts data of key industry players and
makes an extensive and unique segmentation related to the latest market
development.
1.2. Primary Research
The primary research includes gathering data from specific domain
experts through a detailed questionnaire, emails, telephonic interviews, and
web-based surveys. The primary interviewees for this study include an expert
from the demand and supply side, such as CEOs, VPs, directors, sales heads, and
marketing managers of tire 1,2, and 3 companies across the globe.
1.3. Data Triangulation
The data triangulation is very important for any market study, thus we
at Zettabyte Analytics focus on at least three sources to ensure a high level
of accuracy. The data is triangulated by studying various factors and trends
from both supply and demand side. All the reports published and stored in our
repository follows a detailed process to obtain a reliable insight for our
clients.
1.4. In-House Verification
To validate the segmentation
and verify the data collected, our market expert ensures whether our research
analyst is considering fine distinction before analyzing the market.
1.5. Reporting
In the end,
presenting our research reports complied in a different format for straightforward
valuation such as ppt, pdf, and excel data pack is done.
+1 716 953 3077
sales@zettabyteanalytics.com
109 S Warren St, Syracuse, NY 13202, United States